CD47 and neoplasm: To understand the role of CD8+ T lymphocytes following targeting of both CD47 and PD-L1, we examined the proportion of PD-1+CD8+ T cells from lymphocytes isolated from the peripheral blood, spleen, and tumor tissue, respectively, using flow cytometry.